Molina Healthcare (NYSE:MOH) Given New $410.00 Price Target at Wells Fargo & Company

Molina Healthcare (NYSE:MOH) had its target price trimmed by Wells Fargo & Company from $440.00 to $410.00 in a research note published on Monday morning, Benzinga reports. The firm currently has an equal weight rating on the stock.

A number of other equities research analysts have also commented on MOH. Cantor Fitzgerald reissued an overweight rating and issued a $406.00 price target on shares of Molina Healthcare in a research report on Thursday, April 4th. UBS Group increased their target price on shares of Molina Healthcare from $350.00 to $380.00 and gave the company a neutral rating in a report on Thursday, December 21st. Barclays started coverage on shares of Molina Healthcare in a report on Wednesday, March 6th. They set an equal weight rating and a $437.00 price target on the stock. Bank of America lowered shares of Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price objective for the company. in a research note on Thursday, March 28th. Finally, StockNews.com downgraded Molina Healthcare from a strong-buy rating to a buy rating in a research note on Thursday, February 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of Hold and a consensus target price of $393.09.

Molina Healthcare Stock Down 4.2 %

Shares of NYSE MOH opened at $360.84 on Monday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.54 and a quick ratio of 1.54. The company has a 50-day moving average price of $395.20 and a 200-day moving average price of $370.65. The stock has a market capitalization of $21.14 billion, a P/E ratio of 19.21, a P/E/G ratio of 1.06 and a beta of 0.47. Molina Healthcare has a 1 year low of $266.35 and a 1 year high of $423.92.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.31 by $0.07. The business had revenue of $9.05 billion during the quarter, compared to the consensus estimate of $8.35 billion. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The company’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.10 EPS. On average, equities research analysts forecast that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, Director Richard M. Schapiro sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the completion of the sale, the director now owns 11,207 shares in the company, valued at approximately $4,494,567.35. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the sale, the director now directly owns 12,207 shares in the company, valued at approximately $4,688,220.42. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard M. Schapiro sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the transaction, the director now owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders have sold a total of 16,711 shares of company stock worth $6,472,517 over the last three months. 1.11% of the stock is currently owned by insiders.

Institutional Trading of Molina Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the business. Wealth Enhancement Advisory Services LLC grew its stake in Molina Healthcare by 35.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 2,734 shares of the company’s stock valued at $1,123,000 after buying an additional 722 shares in the last quarter. Atlas Capital Advisors LLC raised its stake in shares of Molina Healthcare by 663.0% during the 1st quarter. Atlas Capital Advisors LLC now owns 412 shares of the company’s stock valued at $169,000 after purchasing an additional 358 shares during the period. Gateway Investment Advisers LLC lifted its holdings in Molina Healthcare by 1.6% during the 1st quarter. Gateway Investment Advisers LLC now owns 19,459 shares of the company’s stock worth $7,994,000 after purchasing an additional 314 shares in the last quarter. AdvisorNet Financial Inc boosted its stake in Molina Healthcare by 12.4% in the 1st quarter. AdvisorNet Financial Inc now owns 2,545 shares of the company’s stock worth $1,046,000 after purchasing an additional 281 shares during the period. Finally, Ballentine Partners LLC grew its holdings in Molina Healthcare by 2.0% during the 1st quarter. Ballentine Partners LLC now owns 3,024 shares of the company’s stock valued at $1,242,000 after buying an additional 60 shares in the last quarter. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.